About
Medlyse develops a non-invasive diagnostic device that uses breath-gas biomarker analysis combined with AI to detect diseases rapidly and support early clinical decision-making, targeting applications such as neonatal sepsis and hypoglycaemia.
Explore Medlyse's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.